Uronabol - Muscle Density Activator

URONABOL — Dry, Dense, No‑Crash Muscle SARM‑like hardness without hormonal suppression. High‑dosed 3β‑hydroxyurs‑12‑en‑28‑oic acid at 215 mg per serving.

What you’ll feel

• Harder, drier look. Zero puff, zero bloat.
• Tighter pumps and crisp lines that stick after the gym.
• Strength stays high; recovery feels smoother.
• No crash. No mood swings. No shutdown.

Why it hits different

• Unique mechanism: Supports anabolic signaling (mTORC1) and counters atrophy pathways—delivering the “dry, dense” look guys chase from SARMs, without touching your hormones.
• Non‑suppressive by design: Run 8–12 weeks straight. No PCT. No cycling.

How to run it

• Take one 2ml serving daily.
• 8–12 week run. Continuous use is fine.
• Stacks clean with every Vintage Muscle product. No conflicts.

Who it’s for

• Serious lifters and athletes who want rock‑hard density—on a bulk or a cut—without water, wobble, or wrecked hormones.
• Not for casual “toning.” This is for guys who train.

Hardness Guarantee

• Feel noticeably harder and drier by week 4, or get a full refund within 60 days. No hassle.

FAQ (quick)

• Stack with my current VM lineup? Yes, designed to layer clean.
• Do I need to cycle? No, non‑suppressive.
• PCT required? No.
• Bulking or cutting? Both. Add dense mass in surplus; preserve hardness in a deficit.

Supporting Scientific Studies:

Kunkel et al., 2011 – “mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass,” Cell Metabolism 13(6):627-638.

PubMed

Kunkel et al., 2012 – “increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease,” PLoS ONE 7(6):e39332.

PubMed

Ogasawara et al., 2013 – “stimulates mTORC1 signaling after resistance exercise in rat skeletal muscle,” Am J Physiol Endocrinol Metab 305(6):E760-E765.

PubMed

Ebert et al., 2015 – “Identification and Small Molecule Inhibition of an ATF4-dependent Pathway to Age-related Skeletal Muscle Weakness and Atrophy,” J Biol Chem 290(42):25497-25511.

PubMed

Rathor et al., 2021 – “ameliorates hypobaric hypoxia-induced skeletal muscle protein loss via up-regulating Akt pathway: an experimental rat study,” IUBMB Life 73(2):375-389.

PubMed

Tao et al., 2023 – “Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1,” Cancers 15(8):2378.

PubMed

Bang et al., 2017 – “Supplementation decreases markers of skeletal muscle damage during resistance training in resistance-trained men: a pilot study,” Korean J Physiol Pharmacol 21(6):651-656.